[
  {
    "ts": "2025-10-18T06:08:18+00:00",
    "headline": "A Closer Look at Vertex Pharmaceuticals (VRTX) Valuation After Recent Share Price Stability",
    "summary": "Vertex Pharmaceuticals (VRTX) shares have been fairly steady recently, as investors digest the company’s financial performance over the past month. The stock is up 8% since early May. This reflects a cautious optimism about ongoing growth in the biotech sector. See our latest analysis for Vertex Pharmaceuticals. While Vertex Pharmaceuticals’ 1-day and 1-week share price returns have been positive, it is the rebound since early May that stands out, hinting at growing investor confidence...",
    "url": "https://finance.yahoo.com/news/closer-look-vertex-pharmaceuticals-vrtx-060818009.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "62261bfb-114c-30e1-a774-d6c47c5d6f0c",
      "content": {
        "id": "62261bfb-114c-30e1-a774-d6c47c5d6f0c",
        "contentType": "STORY",
        "title": "A Closer Look at Vertex Pharmaceuticals (VRTX) Valuation After Recent Share Price Stability",
        "description": "",
        "summary": "Vertex Pharmaceuticals (VRTX) shares have been fairly steady recently, as investors digest the company’s financial performance over the past month. The stock is up 8% since early May. This reflects a cautious optimism about ongoing growth in the biotech sector. See our latest analysis for Vertex Pharmaceuticals. While Vertex Pharmaceuticals’ 1-day and 1-week share price returns have been positive, it is the rebound since early May that stands out, hinting at growing investor confidence...",
        "pubDate": "2025-10-18T06:08:18Z",
        "displayTime": "2025-10-18T06:08:18Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/be31617c737d47553e0bc442fa8fa6d9",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ihFoSuY9PLXURl2kI_sV.w--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/be31617c737d47553e0bc442fa8fa6d9.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/bIz6sh0rX4c7ACsVP8z51w--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/be31617c737d47553e0bc442fa8fa6d9.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/closer-look-vertex-pharmaceuticals-vrtx-060818009.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/closer-look-vertex-pharmaceuticals-vrtx-060818009.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "VRTX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]